CareMax, Inc.
CMAX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $199 | $232 | $152 | $202 |
| % Growth | -14.5% | 53% | -24.8% | – |
| Cost of Goods Sold | $196 | $50 | $50 | $183 |
| Gross Profit | $3 | $182 | $102 | $19 |
| % Margin | 1.5% | 78.5% | 67.2% | 9.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15 | $20 | $17 | $19 |
| SG&A Expenses | $16 | $23 | $20 | $23 |
| Sales & Mktg Exp. | $1 | $3 | $4 | $4 |
| Other Operating Expenses | $140 | $1 | $1 | $270 |
| Operating Expenses | $156 | $203 | $184 | $293 |
| Operating Income | -$153 | -$20 | -$82 | -$117 |
| % Margin | -76.9% | -8.7% | -53.9% | -58.1% |
| Other Income/Exp. Net | -$18 | -$22 | -$14 | -$12 |
| Pre-Tax Income | -$170 | -$43 | -$467 | -$103 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$171 | -$43 | -$466 | -$103 |
| % Margin | -85.9% | -18.7% | -306.8% | -51.1% |
| EPS | -44.79 | -11.49 | -124.53 | -27.6 |
| % Growth | -289.8% | 90.8% | -351.2% | – |
| EPS Diluted | -44.79 | -11.49 | -124.53 | -27.6 |
| Weighted Avg Shares Out | 4 | 4 | 4 | 4 |
| Weighted Avg Shares Out Dil | 4 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $20 | $20 | $17 | $14 |
| Depreciation & Amortization | $9 | $9 | $10 | $10 |
| EBITDA | -$141 | -$14 | -$440 | -$79 |
| % Margin | -70.9% | -6.1% | -290.1% | -39.2% |